Droplet Microarray as a Powerful Platform for Seeking New Antibiotics Against Multidrug‐Resistant Bacteria-Reference-Cited by-同舟云学术

Droplet Microarray as a Powerful Platform for Seeking New Antibiotics Against Multidrug‐Resistant Bacteria

Published:2022-07-17 Issue:12 Volume:6 Page:2200166
ISSN:2701-0198
Container-title:Advanced Biology
language:en
Short-container-title:Advanced Biology

Author:

Lei Wenxi¹,Deckers Anke¹,Luchena Charlotte¹,Popova Anna¹,Reischl Markus²,Jung Nicole¹,Bräse Stefan¹³,Schwartz Thomas⁴,Krimmelbein Ilga K.⁵,Tietze Lutz F.⁵,Levkin Pavel A.¹³^ORCID

Affiliation:

1. Institute of Biological and Chemical Systems – Functional Molecular Systems Karlsruhe Institute of Technology Hermann‐von‐Helmholtz Platz 1 76344 Eggenstein‐Leopoldshafen Germany

2. Institute for Automation and Applied Informatics Karlsruhe Institute of Technology Hermann‐von‐Helmholtz Platz 1 76344 Eggenstein‐Leopoldshafen Germany

3. Institute of Organic Chemistry Karlsruhe Institute of Technology 76131 Karlsruhe Germany

4. Institute of Functional Interfaces Karlsruhe Institute of Technology Hermann‐von‐Helmholtz Platz 1 76344 Eggenstein‐Leopoldshafen Germany

5. Institute of Organic and Biomolecular Chemistry Georg‐August‐Universität Tammannstr. 2 D‐37077 Göttingen Germany

Funder

Deutsche Forschungsgemeinschaft

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology,Biomedical Engineering,Biomaterials

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/adbi.202200166

Reference32 articles.

1. Antibiotic Discovery: Where Have We Come from, Where Do We Go?

2. ChIP–seq: advantages and challenges of a maturing technology

3. Antibiotic resistance

4. Breaking the Spell: Combating Multidrug Resistant ‘Superbugs’

5. Methods for in vitro evaluating antimicrobial activity: A review

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High‐Throughput Synthesis and Machine Learning Assisted Design of Photodegradable Hydrogels;Small Methods;2023-06-07

2. Repurposing FDA‐Approved Drugs for Temozolomide‐Resistant IDH1 Mutant Glioma Using High‐Throughput Miniaturized Screening on Droplet Microarray Chip;Advanced Healthcare Materials;2023-05-17